Lipoprotein(a) is a risk factor for aortic andmitral valvular stenosis in peripheral arterial disease

European Heart Journal Cardiovascular Imaging

Volumn 17, Issue 5, 2016, Pages 492-497

  Hojo, Yoshiaki ^a   Kumakura, Hisao ^a   Kanai, Hiroyoshi ^a   Iwasaki, Toshiya ^a   Ichikawa, Shuichi ^a   Kurabayashi, Masahiko ^b  

^a Cardiovascular Hospital of Central Japan (Kitakanto Cardiovascular Hospital)   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aortic valve stenosis; Lipoprotein(a); Mitral valve stenosis; Peripheral arterial disease; Valvular heart disease

Indexed keywords

ALBUMIN; ALPHA 2 ANTIPLASMIN; C REACTIVE PROTEIN; CREATININE; D DIMER; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THROMBIN ANTITHROMBIN COMPLEX; BIOLOGICAL MARKER;

ADULT; AGED; ALBUMIN BLOOD LEVEL; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; TRICUSPID VALVE REGURGITATION; ANGIOGRAPHY; AORTIC VALVE STENOSIS; BLOOD; COMPARATIVE STUDY; COMPLICATION; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEMORAL ARTERY; HEART VALVE DISEASES; ILIAC ARTERY; JAPAN; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; AORTIC VALVE STENOSIS; BIOMARKERS; BODY MASS INDEX; ECHOCARDIOGRAPHY; FEMALE; FEMORAL ARTERY; HEART VALVE DISEASES; HUMANS; ILIAC ARTERY; JAPAN; LIPOPROTEIN(A); MALE; MITRAL VALVE STENOSIS; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84978952312     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jev338     Document Type: Article

References (38)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45(Suppl. S):S5-67.
2. Murphy TP, Dhangana R, Pencina MJ, D'Agostino RB Sr. Ankle-brachial index and cardiovascular risk prediction: an analysis of 11,594 individuals with 10-year followup. Atherosclerosis 2012;220:160-7.
3. Kumakura H, Kanai H, Aizaki M, Mitsui K, Araki Y, Kasama S et al. The influence of the obesity paradox and chronic kidney disease on long-term survival in a Japanese cohort with peripheral arterial disease. J Vasc Surg 2010;52:110-7.
4. Gupta DK, Skali H, Claggett B, Kasabov R, Cheng S, Shah AM et al. Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (atherosclerosis risk in communities). JACC Heart Fail 2014;2:447-54.
5. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999;19:538-45.
6. Berglund L, Ramakrishnan R. Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol 2004;24:2219-26.
7. Dangas G, Mehran R, Harpel PC, Sharma SK, Marcovina SM, Dube G et al. Lipoprotein( a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. J Am Coll Cardiol 1998;32:2035-42.
8. Kamstrup PR, Benn M, Tybjaerg-Hansen A, Nordestgaard BG. Extreme lipoprotein( a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation 2008;117:176-84.
9. Greif M, Arnoldt T, von Ziegler F, Ruemmler J, Becker C,Wakili R et al. Lipoprotein (a) is independently correlated with coronary artery calcification. Eur J Intern Med 2013;24:75-9.
10. Kumakura H, Fujita K, Kanai H, Araki Y, Hojo Y, Kasama S et al. High-sensitivity C-reactive protein, lipoprotein(a) and homocysteine are risk factors for coronary artery disease in japanese patients with peripheral arterial disease. J Atheroscler Thromb 2015;22:344-54.
11. Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med 2013;368:503-12.
12. Kamstrup PR, Tybjaerg-Hansen A, Nordestgaard BG. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J Am Coll Cardiol 2014;63: 470-7.
13. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-92.
14. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148.
15. ZoghbiWA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
16. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009;22:1-23; quiz 101-2.
17. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
18. Aronow WS, Ahn C, Kronzon I. Association of valvular aortic stenosis with symptomatic peripheral arterial disease in older persons. Am J Cardiol 2001;88:1046-7.
19. Adler Y, Levinger U, Koren A, Gabbay R, Shapira Y, Vaturi M et al. Association between mitral annulus calcification and peripheral arterial atherosclerotic disease. Angiology 2000;51:639-46.
20. Anand RG, Ventura HO, Mehra MR. Is heart failure more prevalent in patients with peripheral arterial disease? A meta-analysis. Congest Heart Fail 2007;13:319-22.
21. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-69.
22. Endo M, Kumakura H, Kanai H, Araki Y, Kasama S, Sumino H et al. Prevalence and risk factors for renal artery stenosis and chronic kidney disease in Japanese patients with peripheral arterial disease. Hypertens Res 2010;33:911-5.
23. Araki Y, Kumakura H, Kanai H, Kasama S, Sumino H, Ichikawa A et al. Prevalence and risk factors for cerebral infarction and carotid artery stenosis in peripheral arterial disease. Atherosclerosis 2012;223:473-7.
24. Merjanian R, Budoff M, Adler S, Berman N, Mehrotra R. Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease. Kidney Int 2003;64:263-71.
25. Straumann E, Meyer B, Misteli M, Blumberg A, Jenzer HR. Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br Heart J 1992;67:236-9.
26. Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation 2002;106:2919-24.
27. Gillum RF, Ingram DD, Makuc DM. Relation between serum albumin concentration and stroke incidence and death: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1994;140:876-88.
28. Schalk BW, Visser M, Bremmer MA, Penninx BW, Bouter LM, Deeg DJ. Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam. Am J Epidemiol 2006;164:969-77.
29. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998;32:107-14.
30. Reuben DB, Ferrucci L, Wallace R, Tracy RP, Corti MC, Heimovitz H et al. The prognostic value of serum albumin in healthy older persons with low and high serum interleukin-6 (IL-6) levels. J Am Geriatr Soc 2000;48:1404-7.
31. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000;15:953-60.
32. Ishii H, Aoyama T, Takahashi H, Kamoi D, Tanaka M, Yoshikawa D et al. Serum albumin and C-reactive protein levels predict clinical outcome in hemodialysis patients undergoing endovascular therapy for peripheral artery disease. Atherosclerosis 2013;227:130-4.
33. Gotoh T, Kuroda T, Yamasawa M, Nishinaga M, Mitsuhashi T, Seino Y et al. Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol 1995;76:928-32.
34. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-4.
35. Kumakura H, Kanai H, Araki Y, Kasama S, Sumino H, Ito T et al. Sex-related differences in Japanese patients with peripheral arterial disease. Atherosclerosis 2011;219: 846-50.
36. Egorova N, Vouyouka AG, Quin J, Guillerme S, Moskowitz A, Marin M et al. Analysis of gender-related differences in lower extremity peripheral arterial disease. J Vasc Surg 2010;51:372-8.
37. Shiran A, Najjar R, Adawi S, Aronson D. Risk factors for progression of functional tricuspid regurgitation. Am J Cardiol 2014;113:995-1000.
38. Neuhold S, Huelsmann M, Pernicka E, Graf A, Bonderman D, Adlbrecht C et al. Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study. Eur Heart J 2013;34:844-52.